Filana Therapeutics (FLNA) EV to CFO (2010 - 2026)
Filana Therapeutics (FLNA) posted EV to CFO of 6.57 for Q2 2026, up 1085.98% on a QoQ basis from 0.55 in Q1 2026, and up 30.81% year-over-year from 5.02 in Q2 2025.
Powered by 
Analysis
Filana Therapeutics (FLNA) EV to CFO (2010 - 2026) Analysis & Trends
Filana Therapeutics has reported EV to CFO for 17 years, with the latest figure at 6.57 in Q2 2026.
- On a quarterly basis, EV to CFO rose 30.81% year-over-year to 6.57 in Q2 2026; TTM through Jun 2026 was 0.88, a 236.87% increase from a year earlier, with the FY2025 full-year figure at 0.0, down 103.61% from the prior year.
- EV to CFO was 6.57 for Q2 2026 at Filana Therapeutics, up from 0.55 in the prior quarter.
- The five-year high for EV to CFO was 6.57 in Q2 2026, with the low at 83.71 in Q2 2022.
- Average EV to CFO over 5 years is 29.76, with a median of 29.13 recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: EV to CFO plunged 217.34% in 2024, then surged 123.84% in 2025.
- Over 5 years, EV to CFO stood at 48.4 in 2022, then gained by 23.19% to 37.18 in 2023, then jumped by 100.65% to 0.24 in 2024, then sank by 106.23% to 0.02 in 2025, then surged by 43714.22% to 6.57 in 2026.
- The last three EV to CFO figures came in at 6.57 (Q2 2026), 0.55 (Q1 2026), and 0.02 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Filana Therapeutics | 38.14 Mn | 38.14 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.57 |
| Mar 31, 2026 | 0.55 |
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | -5.56 |
| Jun 30, 2025 | 5.02 |
| Mar 31, 2025 | 3.96 |
| Dec 31, 2024 | 0.24 |
| Sep 30, 2024 | -66.83 |
| Jun 30, 2024 | -21.08 |
| Mar 31, 2024 | -39.39 |
| Dec 31, 2023 | -37.18 |
| Sep 30, 2023 | -21.06 |
| Jun 30, 2023 | -43.14 |
| Mar 31, 2023 | -61.83 |
| Dec 31, 2022 | -48.40 |
| Sep 30, 2022 | -69.63 |
| Jun 30, 2022 | -83.71 |
| Mar 31, 2022 | -54.27 |
| Dec 31, 2021 | -189.72 |
| Sep 30, 2021 | -151.90 |